Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Crispr-Cas System: A Promising Diagnostic Tool for Covid-19 Publisher



Ebrahimi S1 ; Khanbabaei H2 ; Abbasi S3 ; Fani M4 ; Soltani S5 ; Zandi M5 ; Najafimemar Z6
Authors

Source: Avicenna Journal of Medical Biotechnology Published:2022


Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19. © 2022, Avicenna Journal of Medical Biotechnology. All rights reserved.
Other Related Docs
7. The Crispr Growth Spurt: From Bench to Clinic on Versatile Small Rnas, Journal of Microbiology and Biotechnology (2017)
8. The Impact of Crispr-Cas System on Antiviral Therapy, Advanced Pharmaceutical Bulletin (2018)
11. Monkeypox Virus Diagnosis and Laboratory Testing, Reviews in Medical Virology (2023)
12. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
16. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
19. The Role of Medical Imaging in Covid-19, Advances in Experimental Medicine and Biology (2021)
20. Review on Approved and Inprogress Covid-19 Vaccines, Iranian Journal of Pharmaceutical Research (2022)